Chief Development Officer · Vor Biopharma Inc. · Vor Biopharma Inc. — Employee Stock Option (right to buy)
Side
D
Value
—
Shares
218.7K
Price
—
Executed
Dec 5, 2025
Disclosed
Dec 9, 2025
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
Dec 5 executedDec 9, 2025 disclosed
VOR · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disposition to issuer — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Vor Biopharma Inc. — Employee Stock Option (right to buy)
Ticker
VOR
Shares
218.7K
Price per share
$0
Execution date (reported)
Dec 5, 2025
Owned after transaction
0 shares
Days from execution to publication
4
What this establishes
Zuraw Qing Che filed this Form 4 reporting a disposition to issuer of VOR on Dec 5, 2025. It became public on Dec 9, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Development Officer
Zuraw Qing Checik:0002079210
Issuer
Vor Biopharma Inc.cik:0001817229
Revision history · 0
No field has changed since this record was first ingested.
